Small molecule · developed by Abbvie
Biperiden is a small-molecule anticholinergic agent. It is used as an adjunct in parkinsonism and in extrapyramidal disorders caused by neuroleptic drugs, and is also studied in traumatic brain injury and post-traumatic epilepsy.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Oct 16, 2012). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT04945213 | Phase 3 | Brain Injury Traumatic Moderate | Recruiting | RFL |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Brain Injury Traumatic ModerateBrain Injury Traumatic SeverePost Traumatic Epilepsy
Updated Nov 1, 2026.